Skip to content
10-K

Annual Report

IDENIX PHARMACEUTICALS INC

0001193125-14-073142

← back to feed
Filed
Feb 27, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Feb 13, 2014 150.8M sh
Capex FY 2013 · Dec 31, 2013 $1.19M
Capex FY 2013 · Dec 31, 2012 $1.07M
Capex FY 2013 · Dec 31, 2011 $837K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$109.05M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$81.62M
Operating Cash Flow FY 2013 · Dec 31, 2011 −$54.52M
Cash And Equivalents FY 2013 · Dec 31, 2013 $122.01M
Cash And Equivalents FY 2013 · Dec 31, 2012 $230.83M
Cash And Equivalents FY 2013 · Dec 31, 2011 $118.27M
Cash And Equivalents FY 2013 · Dec 31, 2010 $46.12M
Stockholders Equity FY 2013 · Dec 31, 2013 $106M
Stockholders Equity FY 2013 · Dec 31, 2012 $219.16M
Stockholders Equity FY 2013 · Dec 31, 2011 $51.23M
Stockholders Equity FY 2013 · Dec 31, 2010 −$31.1M
Current Liabilities FY 2013 · Dec 31, 2013 $18.19M
Current Liabilities FY 2013 · Dec 31, 2012 $15.93M
Total Liabilities FY 2013 · Dec 31, 2013 $35.01M
Total Liabilities FY 2013 · Dec 31, 2012 $31.71M
Current Assets FY 2013 · Dec 31, 2013 $129.75M
Current Assets FY 2013 · Dec 31, 2012 $237.79M
Total Assets FY 2013 · Dec 31, 2013 $141.01M
Total Assets FY 2013 · Dec 31, 2012 $250.87M
Sga Expense FY 2013 · Dec 31, 2013 $35.32M
Sga Expense FY 2013 · Dec 31, 2012 $24.16M
Sga Expense FY 2013 · Dec 31, 2011 $16.69M
Rd Expense FY 2013 · Dec 31, 2013 $84.25M
Rd Expense FY 2013 · Dec 31, 2012 $70.18M
Rd Expense FY 2013 · Dec 31, 2011 $41.34M
Net Income FY 2013 · Dec 31, 2013 −$28.66M
Net Income FY 2013 · Dec 31, 2013 −$122.29M
Net Income FY 2013 · Sep 30, 2013 −$33.96M
Net Income FY 2013 · Jun 30, 2013 −$28.92M
Net Income FY 2013 · Mar 31, 2013 −$30.75M
Net Income FY 2013 · Dec 31, 2012 −$22.73M
Net Income FY 2013 · Dec 31, 2012 −$32.4M
Net Income FY 2013 · Sep 30, 2012 $4.27M
Net Income FY 2013 · Jun 30, 2012 −$25.4M
Net Income FY 2013 · Mar 31, 2012 $11.45M
Net Income FY 2013 · Dec 31, 2011 −$51.98M
Operating Income FY 2013 · Dec 31, 2013 −$123.72M
Operating Income FY 2013 · Dec 31, 2012 −$35.38M
Operating Income FY 2013 · Dec 31, 2011 −$53.41M
Cost Of Revenue FY 2013 · Dec 31, 2013 $715K
Cost Of Revenue FY 2013 · Dec 31, 2012 $2.65M
Cost Of Revenue FY 2013 · Dec 31, 2011 $2.32M
Revenue FY 2013 · Dec 31, 2013 −$514K
Revenue FY 2013 · Dec 31, 2013 $469K
Revenue FY 2013 · Sep 30, 2013 $19K
Revenue FY 2013 · Jun 30, 2013 $112K
Revenue FY 2013 · Mar 31, 2013 $852K
Revenue FY 2013 · Dec 31, 2012 $327K
Revenue FY 2013 · Dec 31, 2012 $69.66M
Revenue FY 2013 · Sep 30, 2012 $32.25M
Revenue FY 2013 · Jun 30, 2012 $1.44M
Revenue FY 2013 · Mar 31, 2012 $35.65M
Revenue FY 2013 · Dec 31, 2011 $6.95M
Eps Diluted FY 2013 · Dec 31, 2012 −$0.17
Eps Diluted FY 2013 · Dec 31, 2012 −$0.27
Eps Diluted FY 2013 · Sep 30, 2012 $0.03
Eps Diluted FY 2013 · Jun 30, 2012 −$0.23
Eps Diluted FY 2013 · Mar 31, 2012 $0.10
Eps Basic FY 2013 · Dec 31, 2012 −$0.17
Eps Basic FY 2013 · Dec 31, 2012 −$0.27
Eps Basic FY 2013 · Sep 30, 2012 $0.03
Eps Basic FY 2013 · Jun 30, 2012 −$0.23
Eps Basic FY 2013 · Mar 31, 2012 $0.11